TB-500
TB-500, synthetic thymosin beta-4 fragment (Ac-LKKTETQ)
- SKU family:
- TB
- Format:
- Lyophilised powder, sealed glass vial
A peptide listing requiring sequence confirmation for analytical and metabolism research.
$64.00 per single vial before volume savings
Choose 1–10 single vials. For more, switch to 10-vial kits: 10, 20, 30, 40 vials and so on, up to 100 per request.
Add 1 more vial of this strength to save 5%.
1 vial
0% off
$64.00*
2–3 vials
5% off
$60.80*
4–5 vials
10% off
$57.60*
6–7 vials
15% off
$54.40*
8–9 vials
20% off
$51.20*
10+ vials
25% off
$48.00*
Same product and strength only. Above 10 vials, choose whole ten-vial kits (20, 30, 40 and so on). *Approximate price per vial; totals round per line. A valid referral discount applies afterward. Final availability and terms are confirmed before processing.
Typically available within 5–10 business days. Fulfillment timing will be confirmed before processing your research-order request.
Research use only. For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use, diagnostic use, or any form of administration.
No published batch record for this material yet.
Overview
TB-500 has been used inconsistently as a material name. An analytical study identified the N-acetylated thymosin-beta-4 fragment LKKTETQ in a TB-500 preparation and investigated its metabolites using liquid chromatography–mass spectrometry.
TB-500, catalogued in 5 mg or 10 mg nominal fills per vial. Select the exact strength and SKU for your research protocol. Catalog listing and supplier availability do not establish on-hand stock; availability and fulfillment timing are confirmed before a Research Order Request is processed. Nominal fill is a label specification, not a batch assay result. Consult the exact published lot document for any reported analytical result. For laboratory research use only; not for human, veterinary, clinical or diagnostic use.
Research
What researchers study — the questions and models in the cited literature.
- Peptide identity and LC-MS discrimination
- Fragment metabolism and analytical detection
Evidence & research models
Analytical and animal study
In vitro metabolism experiments and equine urine and plasma analysis.
What this evidence does not establish
The seven-residue fragment and full-length thymosin beta-4 are different molecules. Confirm the supplied sequence before selecting literature; full-length-protein findings cannot establish effects of this listing.
Primary research sources
Literature describes the materials and models used by those investigators. It is not a certificate of analysis for current inventory or evidence that this catalog lot was used in a study. For laboratory research only; not for human or veterinary use.
Storage and laboratory handling
Use the storage and handling conditions in the approved documentation for the exact supplied lot. If those conditions have not been supplied, request confirmation before accepting delivery. Packaging visualizations do not establish storage conditions or stability.
Documentation
No published batch record exists for this material yet. We do not state identity, purity, mass, sterility, or endotoxin status without a report for the exact lot.
FAQ
Related products
TB-500 · 5 mg
$64.00